Exclcirc (Suzhou) Biomedical Co., Ltd. recently officially signed a patent licensing agreement with the world's top 10 pharmaceutical company. This will accelerate the layout of the circular RNA industry and lauch more pipelines into pre-clinical and clinical studies soon.